At Work With: Adam Scott Roberts

Adam Scott Roberts, Senior Vice President, Group Media Director, Communications Media Inc.
Adam Scott Roberts, Senior Vice President, Group Media Director, Communications Media Inc.

ADAM SCOTT ROBERTS
Senior Vice President, Group Media Director, Communications Media Inc.

What was your biggest break?
Landing my first job at Carat in Boston. I was part of a small team that helped launch the first paid subscription website for the Wall Street Journal Interactive Edition.

What's the best and/or worst part of your job?
The best part of my job is that no day is ever the same.

Who is the person you admire most in your area of work?
My wife, who is also in the healthcare industry.

What's the view like from your office/work area?
Our Philadelphia office is in the Penthouse of a Center City skyscraper. I can see all of University City.

How long is a typical meeting with clients?
About an hour or more.

What was your greatest professional challenge?
Working a full-time job, growing the media health practice at a global agency and going to Wharton at night for a Marketing Program—and balancing that with raising two amazing daughters.

Where will you be in five years?
Harnessing the power of the tech and healthcare disruption we're experiencing now.

You must be a registered member of MMM to post a comment.
close

Next Article in Careers

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.